The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram

Conclusion: Regulatory changes appear to have produced an important reduction in the high-dose prescribing of citalopram. In contrast to this relatively simple dosage change, there was no indication that the more complex issue of resolving drug–drug interactions was impacted by regulatory warnings.Keywords: citalopram, QT prolongation, safety warnings, interrupted time series
Source: Drug, Healthcare and Patient Safety - Category: Drugs & Pharmacology Tags: Drug, Healthcare and Patient Safety Source Type: research